KWANG DONG PHARMACEUTICAL CO., LTD.
🇹🇼Taiwan
Clinical Trials
6
Active:0
Completed:5
Trial Phases
4 Phases
Phase 1:2
Phase 2:1
Phase 3:2
+1 more phases
Drug Approvals
2
PHILIPPINES:2
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (33.3%)Phase 3
2 (33.3%)Phase 2
1 (16.7%)Phase 4
1 (16.7%)A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)
Phase 3
Completed
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-06-29
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Kwang Dong Pharmaceutical co., ltd.
- Target Recruit Count
- 193
- Registration Number
- NCT04943068
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
Phase 4
Completed
- Conditions
- Vitamin D Deficiency
- Interventions
- Drug: Vitamin D3 B.O.N. Injection
- First Posted Date
- 2017-07-28
- Last Posted Date
- 2017-07-28
- Lead Sponsor
- Kwang Dong Pharmaceutical co., ltd.
- Target Recruit Count
- 108
- Registration Number
- NCT03233295
To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Kwang Dong Pharmaceutical co., ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT02462031
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
Phase 3
Completed
- Conditions
- Vitamin D Deficiency
- Interventions
- Drug: Vitamin D3 B.O.N. Injection (cholecalciferol 200,000IU)Drug: Placebo
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Kwang Dong Pharmaceutical co., ltd.
- Target Recruit Count
- 84
- Registration Number
- NCT02443246
Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects
- First Posted Date
- 2013-11-08
- Last Posted Date
- 2014-08-12
- Lead Sponsor
- Kwang Dong Pharmaceutical co., ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT01979380
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- Next
News
No news found